"Our patient panel demonstrates that—with proper preparation—people living with RA are well equipped to meaningfully contribute to the recommendations that will influence our future treatment," a patient participant said.
Albuquerque, N.M.-based Exagen Diagnostics has raised $25 million in debt financing with a strategic investment from Capital Royalty Partners. The healthcare startup focuses on molecular testing innovations in rheumatology diagnostics, including rheumatoid arthritis and lupus, with its Avise line. Sales success attracted the investor. “The company has shown tremendous sales success with their lead product, […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A British healthcare design firm has come out with a new drug-delivery device to add to its innovative portfolio: an auto-injector for rheumatoid arthritis patients. On its head, this might not sound super-glamorous for a firm like Cambridge Consultants, but the design of Aira is much more user-friendly than many other models currently on the […]
For people with autoimmune disease, the temperature, humidity or barometric pressure on any given day could mean more pain, or less pain, than the day before. Giving those people tools to prepare for what their symptoms might be has so far been a winning idea for mobile health company Predictably Well. While AccuWeather and Weather.com […]
MADRID (IMNG) – Researchers have begun testing whether immunologic modification can forestall rheumatoid arthritis in people at high risk for the disease and also have identified smoking and overweight as two modifiable risk factors strongly linked to disease onset. In a group of 55 people without rheumatoid arthritis (RA) who were enrolled because of a […]